An Alzheimer's pill, ALZ-801, shows promise for those genetically predisposed, slowing cognitive decline and offering a safer alternative to existing treatments.
Philanthropist Tom Golisano generously donates $50 million to Penn State Health Children’s Hospital, elevating standards in pediatric care.
As Halloween presents allergen challenges, a UNC researcher emphasizes the greater need to focus on kids' daily nutritional intake.
David Ressler's retirement as CEO marks the end of an era at Aspen Valley Health, following 18 years of significant growth and community impact.
Longevity guru Dr. Attia shares his 'Medicine 3.0' revolution, urging readers to train for life's final chapter just like athletes.